Nitrofurantoin (UTI in Pregnancy)
Brand names: Macrobid, Furadantin
Nitrofurantoin is an oral urinary antiseptic antibacterial used as a first-line treatment for lower urinary tract infection in pregnancy.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is concentrated in urine and reduced by bacterial enzymes to reactive intermediates that damage bacterial DNA, ribosomal proteins and other macromolecules, giving activity against common urinary pathogens.
Prescribing in practice
- Avoid at term (around the time of delivery) because of the risk of neonatal haemolysis, and avoid in known glucose-6-phosphate dehydrogenase deficiency.
- It is ineffective in pyelonephritis as it does not achieve adequate tissue concentrations, and works only when renal function is adequate to concentrate it in urine.
- Counsel that it may turn the urine dark yellow or brown, and that nausea is common.
Monitoring
Routine monitoring is not required for short courses; reserve longer-term use for specialist settings where pulmonary and hepatic effects are watched for.
Counselling the patient
- Take with food to reduce stomach upset and complete the full course.
- The medicine may darken your urine, which is harmless.
- Tell your midwife or doctor how far along you are, as it is avoided close to delivery.
Evidence & guidelines
Nitrofurantoin is recommended as a first-line option for urinary tract infection in pregnancy in NICE and Public Health antimicrobial guidance, with avoidance near term.
Reference: NICE NG109 (UTI in Adults); MHRA Drug Safety Update 2014 (nitrofurantoin); RCOG UTI in Pregnancy Guidance; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- FeverPAIN Score for Strep Throat · Throat
- Toxoplasmosis Risk Assessment (Congenital and Immunocompromised) · Parasitic Infections
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- Pre-eclampsia Risk Assessment · Antenatal
- VTE Risk in Pregnancy (RCOG) · VTE Prevention